EICHORPublic-registry site landscape for NCT05083260, “NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa”, a Parkinson Disease study sponsored by BioVie Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05083260 (registry record) |
| Study title | NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa |
| Official title | A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's Disease (PD) Participants Treated With Carbidopa/Levodopa and NE3107 |
| Sponsor | BioVie Inc. |
| Condition(s) | Parkinson Disease |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 16 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05083260.
Eichor generates a preliminary site-risk snapshot for NCT05083260 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Parkinson Disease trials
More from BioVie Inc.
← Eichor home · All tracked trials · Parkinson Disease studies · Weekly briefs
